{"organizations": [], "uuid": "c678049262c1dabcf980ab0e4a2eace7690fe78b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-centene-makes-initial-investment-i/brief-centene-makes-initial-investment-in-pharmacy-benefit-manager-rxadvance-idUSL8N1QV2XI", "country": "US", "domain_rank": 408, "title": "BRIEF-Centene Makes Initial Investment In Pharmacy Benefit Manager, RxAdvance", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-13T12:17:00.000+02:00", "replies_count": 0, "uuid": "c678049262c1dabcf980ab0e4a2eace7690fe78b"}, "author": "", "url": "https://www.reuters.com/article/brief-centene-makes-initial-investment-i/brief-centene-makes-initial-investment-in-pharmacy-benefit-manager-rxadvance-idUSL8N1QV2XI", "ord_in_thread": 0, "title": "BRIEF-Centene Makes Initial Investment In Pharmacy Benefit Manager, RxAdvance", "locations": [], "entities": {"persons": [], "locations": [{"name": "rxadvance", "sentiment": "none"}], "organizations": [{"name": "rxadvance reuters", "sentiment": "none"}, {"name": "centene", "sentiment": "none"}, {"name": "centene corp", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "centene corp", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 18 AM / Updated 14 minutes ago BRIEF-Centene Makes Initial Investment In Pharmacy Benefit Manager, RxAdvance Reuters Staff March 13 (Reuters) - Centene Corp:​ * CENTENE AND RXADVANCE ESTABLISH TRANSFORMATIVE PARTNERSHIP TO CREATE NEXT GENERATION PHARMACY MANAGEMENT SOLUTION * CENTENE SAYS MADE INITIAL INVESTMENT IN RXADVANCE, A FULL-SERVICE PHARMACY BENEFIT MANAGER * CENTENE CORP - ‍RAVI IKA WILL CONTINUE IN HIS CURRENT ROLE AS CEO OF RXADVANCE * CENTENE CORP - AS PART OF INITIAL TRANSACTION, CENTENE HAS CERTAIN RIGHTS TO EXPAND ITS EQUITY INVESTMENT IN FUTURE Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-03-13T12:17:00.000+02:00", "crawled": "2018-03-13T12:38:46.004+02:00", "highlightTitle": ""}